Ratings by Piper Sandler (Christopher J. Raymond)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/17/2024 | Abivax | ABVX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/11/2024 | Q32 Bio Inc. | QTTB | Maintain | Overweight (N/A) |
|
Details | ||
| 11/25/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Overweight (Overweight) |
|
Details | ||
| 9/26/2024 | Abivax | ABVX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/23/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Overweight (N/A) |
|
Details | ||
| 4/23/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Overweight (N/A) |
|
Details | ||
| 4/15/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/15/2023 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/26/2022 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/12/2022 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Overweight (N/A) |
11.79 (9.92) |
-15.86% | Details | |
| 12/15/2020 | ALX Oncology | ALXO | Maintain | Overweight (N/A) |
|
Details | ||
| 12/7/2020 | ALX Oncology | ALXO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/1/2020 | AMAG Pharmaceuticals | AMAG | Upgrade | Neutral (Underweight) |
9.40 (13.75) |
46.28% | Details |
